INR 492.5
(6.9%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 2.94 Billion INR | 5.75% |
2022 | 2.78 Billion INR | 23.41% |
2021 | 2.25 Billion INR | 16.5% |
2020 | 1.93 Billion INR | 6.86% |
2019 | 1.81 Billion INR | 32.72% |
2018 | 1.36 Billion INR | 16.2% |
2017 | 1.17 Billion INR | 60.15% |
2016 | 734 Million INR | 22.3% |
2015 | 600.18 Million INR | -12.59% |
2014 | 686.62 Million INR | 6.32% |
2013 | 645.78 Million INR | -1.0% |
2012 | 652.34 Million INR | -5.33% |
2011 | 689.07 Million INR | -1.59% |
2010 | 700.18 Million INR | 21.38% |
2009 | 576.82 Million INR | 25.92% |
2008 | 458.1 Million INR | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | - INR | -100.0% |
2023 Q4 | 2.94 Billion INR | 0.0% |
2023 Q3 | - INR | -100.0% |
2023 Q2 | 2.97 Billion INR | 0.0% |
2023 FY | 2.94 Billion INR | 5.75% |
2023 Q1 | - INR | -100.0% |
2022 Q2 | 2.58 Billion INR | 0.0% |
2022 FY | 2.78 Billion INR | 23.41% |
2022 Q3 | - INR | -100.0% |
2022 Q4 | 2.78 Billion INR | 0.0% |
2022 Q1 | - INR | -100.0% |
2021 Q4 | 2.25 Billion INR | 0.0% |
2021 Q3 | - INR | -100.0% |
2021 Q2 | 2.03 Billion INR | 0.0% |
2021 Q1 | - INR | -100.0% |
2021 FY | 2.25 Billion INR | 16.5% |
2020 Q1 | - INR | -100.0% |
2020 FY | 1.93 Billion INR | 6.86% |
2020 Q4 | 1.93 Billion INR | 0.0% |
2020 Q3 | - INR | -100.0% |
2020 Q2 | 1.84 Billion INR | 0.0% |
2019 Q4 | 1.81 Billion INR | 0.0% |
2019 Q3 | - INR | -100.0% |
2019 FY | 1.81 Billion INR | 32.72% |
2019 Q2 | 1.62 Billion INR | 0.0% |
2019 Q1 | - INR | -100.0% |
2018 Q3 | - INR | -100.0% |
2018 Q2 | 1.23 Billion INR | 0.0% |
2018 Q1 | - INR | -100.0% |
2018 FY | 1.36 Billion INR | 16.2% |
2018 Q4 | 1.36 Billion INR | 0.0% |
2017 Q3 | - INR | -100.0% |
2017 Q1 | - INR | -100.0% |
2017 Q4 | 1.17 Billion INR | 0.0% |
2017 FY | 1.17 Billion INR | 60.15% |
2017 Q2 | 889.77 Million INR | 0.0% |
2016 Q2 | 666.45 Million INR | 0.0% |
2016 FY | 734 Million INR | 22.3% |
2016 Q1 | - INR | -100.0% |
2016 Q3 | - INR | -100.0% |
2016 Q4 | 734 Million INR | 0.0% |
2015 Q2 | 675.62 Million INR | 0.0% |
2015 Q4 | 600.18 Million INR | 0.0% |
2015 Q1 | - INR | -100.0% |
2015 Q3 | - INR | -100.0% |
2015 FY | 600.18 Million INR | -12.59% |
2014 Q3 | - INR | -100.0% |
2014 FY | 686.62 Million INR | 6.32% |
2014 Q4 | 686.62 Million INR | 0.0% |
2014 Q2 | 674.95 Million INR | 0.0% |
2014 Q1 | - INR | -100.0% |
2013 Q1 | - INR | -100.0% |
2013 Q3 | - INR | -100.0% |
2013 Q4 | 645.78 Million INR | 0.0% |
2013 FY | 645.78 Million INR | -1.0% |
2013 Q2 | 600.49 Million INR | 0.0% |
2012 Q2 | 652.59 Million INR | 0.0% |
2012 FY | 652.34 Million INR | -5.33% |
2012 Q4 | 652.34 Million INR | 0.0% |
2011 FY | 689.07 Million INR | -1.59% |
2011 Q4 | 689.07 Million INR | 0.0% |
2010 FY | 700.18 Million INR | 21.38% |
2009 FY | 576.82 Million INR | 25.92% |
2008 FY | 458.1 Million INR | 0.0% |
2008 Q4 | 458.1 Million INR | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Alembic Pharmaceuticals Limited | 64.45 Billion INR | 95.431% |
Aurobindo Pharma Limited | 450.71 Billion INR | 99.347% |
Glenmark Life Sciences Limited | 28.5 Billion INR | 89.667% |
Granules India Limited | 55.2 Billion INR | 94.665% |
Indoco Remedies Limited | 21.44 Billion INR | 86.268% |
Achyut Healthcare Limited | 309.52 Million INR | -851.539% |
Ajanta Pharma Limited | 46.38 Billion INR | 93.65% |
Alkem Laboratories Limited | 155.74 Billion INR | 98.109% |
Alpa Laboratories Limited | 1.82 Billion INR | -61.275% |
Brooks Laboratories Limited | 904.45 Million INR | -225.636% |
AstraZeneca Pharma India Limited | 10.78 Billion INR | 72.68% |
Bajaj HealthCare Limited | 7.65 Billion INR | 61.507% |
Bliss GVS Pharma Limited | 12.13 Billion INR | 75.737% |
Dr. Reddy's Laboratories Limited | 387.51 Billion INR | 99.24% |
Eris Lifesciences Limited | 70.48 Billion INR | 95.822% |
FDC Limited | 24.68 Billion INR | 88.067% |
Glenmark Pharmaceuticals Limited | 143.58 Billion INR | 97.949% |
Gufic Biosciences Limited | 10.92 Billion INR | 73.042% |
Ind-Swift Laboratories Limited | 11.65 Billion INR | 74.721% |
Ipca Laboratories Limited | 111.01 Billion INR | 97.347% |
Jagsonpal Pharmaceuticals Limited | 2.17 Billion INR | -35.676% |
Krebs Biochemicals & Industries Limited | 1.78 Billion INR | -65.3% |
Lasa Supergenerics Limited | 1.5 Billion INR | -95.218% |
Laurus Labs Limited | 83.87 Billion INR | 96.488% |
Lupin Limited | 239.97 Billion INR | 98.773% |
Mankind Pharma Limited | 119.63 Billion INR | 97.538% |
Medico Remedies Limited | 961.95 Million INR | -206.171% |
Megasoft Limited | 3.65 Billion INR | 19.507% |
NATCO Pharma Limited | 69.06 Billion INR | 95.735% |
Piramal Pharma Limited | 153.11 Billion INR | 98.077% |
RPG Life Sciences Limited | 5.12 Billion INR | 42.574% |
Sigachi Industries Limited | 6.94 Billion INR | 57.571% |
Sun Pharmaceutical Industries Limited | 854.62 Billion INR | 99.655% |
Suven Pharmaceuticals Limited | 22.54 Billion INR | 86.934% |
Syncom Formulations (India) Limited | 4.04 Billion INR | 27.218% |
Unichem Laboratories Limited | 31.69 Billion INR | 90.707% |
Wanbury Limited | 3.43 Billion INR | 14.257% |
Windlas Biotech Limited | 6.26 Billion INR | 52.967% |
ZIM Laboratories Limited | 4.46 Billion INR | 34.085% |
Zydus Lifesciences Limited | 292.8 Billion INR | 98.994% |
Sun Pharma Advanced Research Company Limited | 5.15 Billion INR | 42.816% |
Divi's Laboratories Limited | 154.7 Billion INR | 98.096% |
Hester Biosciences Limited | 6.62 Billion INR | 55.534% |
Procter & Gamble Health Limited | 7.94 Billion INR | 62.923% |
Amrutanjan Health Care Limited | 3.66 Billion INR | 19.72% |
Bal Pharma Limited | 3.2 Billion INR | 8.073% |
Strides Pharma Science Limited | 58.39 Billion INR | 94.957% |
Venus Remedies Limited | 6.26 Billion INR | 53.014% |
Aarti Pharmalabs Limited | 25.82 Billion INR | 88.594% |
Nectar Lifesciences Limited | 21.91 Billion INR | 86.558% |
Shilpa Medicare Limited | 30.93 Billion INR | 90.478% |
Aarti Drugs Limited | 24.32 Billion INR | 87.891% |
IOL Chemicals and Pharmaceuticals Limited | 22.44 Billion INR | 86.877% |
Suven Life Sciences Limited | 2.84 Billion INR | -3.376% |
Ind-Swift Limited | 6.54 Billion INR | 54.998% |
Valiant Laboratories Limited | 3.42 Billion INR | 14.055% |
J. B. Chemicals & Pharmaceuticals Limited | 39.94 Billion INR | 92.626% |
Solara Active Pharma Sciences Limited | 23.5 Billion INR | 87.472% |
Themis Medicare Limited | 5.66 Billion INR | 48.003% |
Hikal Limited | 24.87 Billion INR | 88.158% |
Torrent Pharmaceuticals Limited | 150.61 Billion INR | 98.044% |
Sequent Scientific Limited | 15.4 Billion INR | 80.88% |
Novartis India Limited | 9.24 Billion INR | 68.157% |
Wockhardt Limited | 76.49 Billion INR | 96.15% |
Jubilant Pharmova Limited | 115.48 Billion INR | 97.45% |
Biofil Chemicals and Pharmaceuticals Limited | 470.82 Million INR | -525.543% |
Neuland Laboratories Limited | 18.32 Billion INR | 83.928% |
Morepen Laboratories Limited | 12.93 Billion INR | 77.225% |
Kilitch Drugs (India) Limited | 2.4 Billion INR | -22.686% |
Mangalam Drugs & Organics Limited | 3.33 Billion INR | 11.667% |